Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2015

Sep 29, 2015

34023_dirs_2015-09-29_441e6ae2-32d2-4d13-9787-fc508ad1b0c5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2015-09-25

Reporting Person: ARMEN GARO H (Chairman & CEO)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1309607 Direct
Common Stock 304046 Indirect

Footnotes

F1: The original Form 4 was filed in error and should be disregarded. Dr. Armen did not acquire additional shares or dispose of shares on the date reported. The holdings reflected on Table I of this amendment to the Form 4 were taken from the Dr. Armen's last Form 4 dated June 27, 2014 and are being reported for the purpose of accessing the filing system.

F2: Dr. Armen is trustee and has investment authority for the Garo Armen 2014 2 Year GRAT holding 300,000 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.